Industry:
Drug Manufacturing,
Pharmaceuticals,
Biotechnology
Curis will be positioned to identify and successfully commercialize therapeutic opportunities derived from the human genome program , said Doros Platika , MD , president and chief executive officer of Ontogeny who will serve as president and chief executive officer of Curis. The technologies at Curis will represent a powerful system to identify target genes that may restore function through repair and regeneration. Curis technology platform has already identified protein , small molecule and stem cell product opportunities. The Company is further backed by leading corporate partners and sustainable financial strength , including near-term product revenue opportunities..
Contact with Curis , Inc.:
61 Moulton Street
Cambridge,
Massachusetts
02138
USA
Tel: (617) 503-6500
Fax: (617) 876-0866
Web Site: www.curis.com
Instant Messenger:
N/A